CRISPR Therapeutics AG (CRSP) EBITDA Margin Growth (3y) (2019 - 2026)
CRISPR Therapeutics AG (CRSP) EBITDA Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - | -886,885.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -886,885.00 |
| Dec 31, 2025 | 217.44 Mn |
| Sep 30, 2025 | 17.92 Mn |
| Jun 30, 2025 | 9.03 Mn |
| Mar 31, 2025 | 156,158.00 |
| Dec 31, 2024 | 94,857.00 |
| Sep 30, 2024 | -265,701.00 |
| Jun 30, 2024 | -2.93 Mn |
| Mar 31, 2024 | -664,323.00 |
| Dec 31, 2023 | 2.92 Mn |
| Jun 30, 2023 | 18.32 Mn |
| Mar 31, 2023 | 4.68 Mn |
| Dec 31, 2022 | -219.24 Mn |
| Sep 30, 2022 | -19.41 Mn |
| Jun 30, 2022 | -9.87 Mn |
| Mar 31, 2022 | -395,732.00 |
| Dec 31, 2021 | 3.82 Mn |
| Sep 30, 2021 | -685,691.00 |
| Jun 30, 2021 | 351,169.00 |
| Mar 31, 2021 | -1.93 Mn |